Cms-10434 #26 Cqm2018-apc-ch

Centers for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
CQM 2018 - Use of Multiple Concurrent
Antipsychotics in Children and Adolescents
(APC-CH) Core Measure PRA Document
Version 1.0
06/25/2018

Document Number: 383-CQM 2018 APC-CH-PRA-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APCCH) Screenshots ...................................................................................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
1.11
1.12

Measurement Specifications – Path 1 ............................................................. 1
Measurement Specifications – Path 2 ............................................................. 1
Data Source .................................................................................................... 1
Date Range ..................................................................................................... 2
Definition of Population Included in the Measure ............................................ 3
Performance Measure - Path 1 ....................................................................... 4
Performance Measure - Path 2 ....................................................................... 4
Deviations from Measure Specifications ......................................................... 5
Combined Rate(s) from Multiple Reporting Units – Path 1 .............................. 6
Additional Notes/Comments on Measure (Optional) ....................................... 6
Optional Measure Stratification – Screenshot 1 .............................................. 6
Optional Measure Stratification – Screenshot 2 .............................................. 7

Appendix A: Acronyms ................................................................................................. 8

List of Figures
Figure 1: Measurement Specifications – Path 1 .............................................................. 1
Figure 2: Measurement Specifications – Path 2 .............................................................. 1
Figure 3: Data Source ..................................................................................................... 1
Figure 4: Date Range ...................................................................................................... 2
Figure 5: Definition of Population Included in the Measure ............................................. 3
Figure 6: Performance Measure - Path 1 ........................................................................ 4
Figure 7: Performance Measure - Path 2 ........................................................................ 4
Figure 8: Deviations from Measure Specifications .......................................................... 5
Figure 9: Combined Rate(s) from Multiple Reporting Units ............................................. 6
Figure 10 : Additional Notes/Comments on Measure ...................................................... 6
Figure 11: Optional Measure Stratification – Screenshot 1 ............................................. 6
Figure 12: Optional Measure Stratification – Screenshot 2 ............................................. 7

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
i
06/25/2018

CMS XLC

List of Tables

List of Tables
No table of figures entries found.

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
ii
06/25/2018

CMS XLC

Measurement Specifications – Path 1

1. Use of Multiple Concurrent Antipsychotics in Children
and Adolescents (APC-CH) Screenshots
1.1

Measurement Specifications – Path 1

Figure 1: Measurement Specifications – Path 1

1.2

Measurement Specifications – Path 2

Figure 2: Measurement Specifications – Path 2

1.3

Data Source

Figure 3: Data Source

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
1
06/25/2018

CMS XLC

1.4

Date Range

Date Range

Figure 4: Date Range

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
2
06/25/2018

CMS XLC

1.5

Definition of Population Included in the Measure

Definition of Population Included in the Measure

Figure 5: Definition of Population Included in the Measure

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
3
06/25/2018

CMS XLC

1.6

Performance Measure - Path 1

Performance Measure - Path 1

Figure 6: Performance Measure - Path 1

1.7

Performance Measure - Path 2

Figure 7: Performance Measure - Path 2

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
4
06/25/2018

CMS XLC

1.8

Deviations from Measure Specifications

Deviations from Measure Specifications

Note: Same N/D/R sets are displayed under each of the Age categories

Figure 8: Deviations from Measure Specifications

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
5
06/25/2018

CMS XLC

1.9

Combined Rate(s) from Multiple Reporting Units – Path 1

Combined Rate(s) from Multiple Reporting Units – Path 1

Figure 9: Combined Rate(s) from Multiple Reporting Units

1.10 Additional Notes/Comments on Measure (Optional)

Figure 10 : Additional Notes/Comments on Measure

1.11 Optional Measure Stratification – Screenshot 1
Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 11: Optional Measure Stratification – Screenshot 1

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
6
06/25/2018

CMS XLC

Optional Measure Stratification – Screenshot 2

1.12 Optional Measure Stratification – Screenshot 2
Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 12: Optional Measure Stratification – Screenshot 2

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
7
06/25/2018

CMS XLC

Optional Measure Stratification – Screenshot 2

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Definition

CQM

Child Quality Measures

PRA

Paperwork Reduction Act of 1995

CQM 2018 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC-CH) Core Measure PRA Document Version
1.0
8
06/25/2018